Editorial: Innovative immunotherapy strategies for enhanced treatment of Hodgkin and non-Hodgkin lymphomas
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1642505/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849689386513334272 |
|---|---|
| author | Michael J. Robertson Eric Vivier Penny Fang |
| author_facet | Michael J. Robertson Eric Vivier Penny Fang |
| author_sort | Michael J. Robertson |
| collection | DOAJ |
| format | Article |
| id | doaj-art-d03e0e787a4048ef978740086c869f97 |
| institution | DOAJ |
| issn | 1664-3224 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj-art-d03e0e787a4048ef978740086c869f972025-08-20T03:21:39ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-06-011610.3389/fimmu.2025.16425051642505Editorial: Innovative immunotherapy strategies for enhanced treatment of Hodgkin and non-Hodgkin lymphomasMichael J. Robertson0Eric Vivier1Penny Fang2Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN, United StatesCentre d’Immunologie de Marseille-Luminy, Marseille, FranceDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United Stateshttps://www.frontiersin.org/articles/10.3389/fimmu.2025.1642505/fulllymphomaimmunotherapyCAR (chimeric antigen receptor) T-cell therapyimmune checkpoint inhibitorsmonoclonal Abs |
| spellingShingle | Michael J. Robertson Eric Vivier Penny Fang Editorial: Innovative immunotherapy strategies for enhanced treatment of Hodgkin and non-Hodgkin lymphomas Frontiers in Immunology lymphoma immunotherapy CAR (chimeric antigen receptor) T-cell therapy immune checkpoint inhibitors monoclonal Abs |
| title | Editorial: Innovative immunotherapy strategies for enhanced treatment of Hodgkin and non-Hodgkin lymphomas |
| title_full | Editorial: Innovative immunotherapy strategies for enhanced treatment of Hodgkin and non-Hodgkin lymphomas |
| title_fullStr | Editorial: Innovative immunotherapy strategies for enhanced treatment of Hodgkin and non-Hodgkin lymphomas |
| title_full_unstemmed | Editorial: Innovative immunotherapy strategies for enhanced treatment of Hodgkin and non-Hodgkin lymphomas |
| title_short | Editorial: Innovative immunotherapy strategies for enhanced treatment of Hodgkin and non-Hodgkin lymphomas |
| title_sort | editorial innovative immunotherapy strategies for enhanced treatment of hodgkin and non hodgkin lymphomas |
| topic | lymphoma immunotherapy CAR (chimeric antigen receptor) T-cell therapy immune checkpoint inhibitors monoclonal Abs |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1642505/full |
| work_keys_str_mv | AT michaeljrobertson editorialinnovativeimmunotherapystrategiesforenhancedtreatmentofhodgkinandnonhodgkinlymphomas AT ericvivier editorialinnovativeimmunotherapystrategiesforenhancedtreatmentofhodgkinandnonhodgkinlymphomas AT pennyfang editorialinnovativeimmunotherapystrategiesforenhancedtreatmentofhodgkinandnonhodgkinlymphomas |